Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration
Objective: Antibody persistence evaluation for all antigens of a fully liquid DTaP-IPV-HB-PRP~T vaccine at 3.5 and 4.5 y of age following different primary series and booster schedules in South Africa and Latin America. Methods: Participants had completed one of two previous studies (Study 1-South A...
Main Authors: | Shabir A. Madhi, Pío López, Betzana Zambrano, Emilia Jordanov, Siham B’Chir, Fernando Noriega, Emmanuel Feroldi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-03-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2018.1546524 |
Similar Items
-
Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
by: Pope Kosalaraksa, et al.
Published: (2018-05-01) -
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
by: S Mangarule, et al.
Published: (2022-08-01) -
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India
by: S. Mangarule, et al.
Published: (2022-04-01) -
Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa
by: Anthonet Koen, et al.
Published: (2021-06-01) -
Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines
by: Timo Vesikari, et al.
Published: (2020-04-01)